Mona Al‐Ahmad

4.3k total citations · 1 hit paper
83 papers, 713 citations indexed

About

Mona Al‐Ahmad is a scholar working on Physiology, Immunology and Allergy and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mona Al‐Ahmad has authored 83 papers receiving a total of 713 indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Physiology, 33 papers in Immunology and Allergy and 29 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mona Al‐Ahmad's work include Asthma and respiratory diseases (45 papers), Allergic Rhinitis and Sensitization (29 papers) and Respiratory and Cough-Related Research (18 papers). Mona Al‐Ahmad is often cited by papers focused on Asthma and respiratory diseases (45 papers), Allergic Rhinitis and Sensitization (29 papers) and Respiratory and Cough-Related Research (18 papers). Mona Al‐Ahmad collaborates with scholars based in Kuwait, Bosnia and Herzegovina and China. Mona Al‐Ahmad's co-authors include Nermina Arifhodžić, Waleed Al–Herz, Pedro Giavina‐Bianchi, Juan Carlos Vázquez-García, C.A. Celis-Preciado, Arzu Yorgancıoğlu, Yochai Adir, Diahn‐Warng Perng, Jorge Máspero and Hani Lababidi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Allergy and Clinical Immunology and The American Journal of Cardiology.

In The Last Decade

Mona Al‐Ahmad

77 papers receiving 692 citations

Hit Papers

Type 2 inflammation in asthma and other airway diseases 2022 2026 2023 2024 2022 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mona Al‐Ahmad Kuwait 14 361 242 194 116 96 83 713
Bob Geng United States 14 179 0.5× 111 0.5× 127 0.7× 142 1.2× 88 0.9× 52 492
Adile Berna Dursun Türkiye 18 416 1.2× 198 0.8× 226 1.2× 63 0.5× 140 1.5× 53 962
Jennifer A. Namazy United States 14 295 0.8× 135 0.6× 155 0.8× 232 2.0× 35 0.4× 41 838
Tung‐Jung Huang Taiwan 16 338 0.9× 82 0.3× 184 0.9× 158 1.4× 21 0.2× 44 815
Oliviero Rossi Italy 18 460 1.3× 434 1.8× 175 0.9× 322 2.8× 265 2.8× 60 1.1k
Martyn Barnes United Kingdom 13 530 1.5× 336 1.4× 244 1.3× 32 0.3× 39 0.4× 32 874
Albert F. Finn United States 14 541 1.5× 509 2.1× 230 1.2× 77 0.7× 142 1.5× 23 800
Yongchang Sun China 20 456 1.3× 56 0.2× 646 3.3× 323 2.8× 29 0.3× 72 1.2k
Andrew J. MacGinnitie United States 14 152 0.4× 302 1.2× 68 0.4× 147 1.3× 88 0.9× 40 643
Robert G. Price United Kingdom 15 1.1k 3.2× 311 1.3× 875 4.5× 224 1.9× 28 0.3× 62 1.3k

Countries citing papers authored by Mona Al‐Ahmad

Since Specialization
Citations

This map shows the geographic impact of Mona Al‐Ahmad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mona Al‐Ahmad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mona Al‐Ahmad more than expected).

Fields of papers citing papers by Mona Al‐Ahmad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mona Al‐Ahmad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mona Al‐Ahmad. The network helps show where Mona Al‐Ahmad may publish in the future.

Co-authorship network of co-authors of Mona Al‐Ahmad

This figure shows the co-authorship network connecting the top 25 collaborators of Mona Al‐Ahmad. A scholar is included among the top collaborators of Mona Al‐Ahmad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mona Al‐Ahmad. Mona Al‐Ahmad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Al‐Ahmad, Mona, et al.. (2025). Improving asthma outcomes in Kuwait through a standardized emergency department algorithm. World Allergy Organization Journal. 18(7). 101070–101070.
2.
Al-Moamary, Mohamed, Bhumika Aggarwal, Mona Al‐Ahmad, et al.. (2025). Are Treatment Adherence Factors Apparent in Patients with Asthma and to Physicians? Results from the APPaRENT 3 Survey. Advances in Therapy. 42(3). 1506–1521. 1 indexed citations
3.
4.
Al‐Ahmad, Mona, et al.. (2024). Exploring the immunopathology of type 2 inflammatory airway diseases. Frontiers in Immunology. 15. 1285598–1285598. 16 indexed citations
5.
Chu, Chia‐Yu, Hilde Lapeere, Mariateresa Rossi, et al.. (2024). One-Year Insights into the GLOBOSTAD Multinational Prospective Observational Study of Patients Receiving Dupilumab for Atopic Dermatitis. Advances in Therapy. 42(2). 720–733. 2 indexed citations
6.
Al‐Lehebi, Riyad, Mona Al‐Ahmad, Venkata Nagarjuna Maturu, et al.. (2024). Real-World Effectiveness of Mepolizumab in Severe Asthma: Results from the Multi-country, Self-controlled Nucala Effectiveness Study (NEST). Advances in Therapy. 41(11). 4008–4031. 6 indexed citations
7.
Al‐Ahmad, Mona, et al.. (2024). Expert consensus on oral corticosteroids stewardship for the treatment of severe asthma in the Middle East and Africa. Respiratory Medicine. 228. 107674–107674. 2 indexed citations
8.
Al‐Ahmad, Mona, et al.. (2023). Nationwide study of rates of reinfection with SARS-CoV-2 among adults in Kuwait. Eastern Mediterranean Health Journal. 29(2). 146–150. 2 indexed citations
9.
Al‐Ahmad, Mona, Asmaa Ali, & Ahmed Maher. (2023). Factors influencing poor response to type 2 targeted therapies in severe asthma: a retrospective cohort study. BMC Pulmonary Medicine. 23(1). 490–490. 4 indexed citations
10.
Marglani, Osama, et al.. (2023). Management of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in the Pan-Arab Region: Consensus Recommendations from a Multidisciplinary Expert Working Group. Journal of Asthma and Allergy. Volume 16. 1055–1063. 3 indexed citations
11.
Calzavara‐Pinton, Piergiacomo, Jarmila Čelakovská, Hilde Lapeere, et al.. (2023). Baseline Demographics, Comorbidities, Treatment Patterns and Burden of Atopic Dermatitis in Adults and Adolescents from the GLOBOSTAD Long-Term Observational Study. Advances in Therapy. 40(12). 5366–5382. 3 indexed citations
12.
Al‐Ahmad, Mona, Saad Alsaleh, Iman Nasr, et al.. (2022). Expert Opinion on Biological Treatment of Chronic Rhinosinusitis with Nasal Polyps in the Gulf Region. SHILAP Revista de lepidopterología. 14 indexed citations
13.
Maurer, Marcus, Mohamed Abuzakouk, Mona Al‐Ahmad, et al.. (2022). Consensus on diagnosis and management of Hereditary Angioedema in the Middle East: A Delphi initiative. World Allergy Organization Journal. 16(1). 100729–100729. 4 indexed citations
15.
Al‐Ahmad, Mona, et al.. (2021). Peanut Component Ara h 1 and 2 Sensitization in Patients with Food Allergy in Kuwait. International Archives of Allergy and Immunology. 183(3). 315–321. 2 indexed citations
16.
Al‐Ahmad, Mona, et al.. (2019). Sensitization to Cat: When Is Nasal Challenge Needed?. International Archives of Allergy and Immunology. 179(2). 108–113. 11 indexed citations
17.
Blanca‐López, Natalia, María Luisa Somoza, Enrique Gómez Alcaide, et al.. (2019). Allergic reactions to penicillins and cephalosporins: diagnosis, assessment of cross-reactivity and management. Expert Review of Clinical Immunology. 15(7). 707–721. 10 indexed citations
18.
Al‐Ahmad, Mona, et al.. (2018). Most common, real life factors affecting effectiveness of omalizumab asthma treatment: a 10-year study. Medicinski Glasnik. 16(1). 45–52. 5 indexed citations
19.
Al‐Ahmad, Mona, et al.. (2018). "Real-life" Efficacy and Safety Aspects of 4-Year Omalizumab Treatment for Asthma. Medical Principles and Practice. 27(3). 260–266. 19 indexed citations
20.
Al‐Ahmad, Mona, et al.. (2009). Symptoms after mould exposure including Stachybotrys chartarum, and comparison with darkroom disease. Allergy. 65(2). 245–255. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026